C-reactive protein (CRP), procalcitonin (PCT), and presepsin are practical to be used in daily clinical practice and were evaluated in patients with different stages of LC as the markers of infections or sepsis [10,11,12]. This evidence concerns the gene CRP and laryngotracheoesophageal cleft.